Samsara BioCapital as of Sept. 30, 2023
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 41 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mineralys Therapeutics (MLYS) | 13.2 | $43M | 4.5M | 9.51 | |
| Rayzebio | 12.5 | $41M | 1.8M | 22.20 | |
| Scholar Rock Hldg Corp (SRRK) | 10.0 | $33M | 4.6M | 7.10 | |
| Acelyrin (SLRN) | 7.4 | $24M | 2.4M | 10.17 | |
| Arcellx Common Stock (ACLX) | 6.7 | $22M | 614k | 35.88 | |
| Graphite Bio | 6.4 | $21M | 8.5M | 2.48 | |
| Intercept Pharmaceuticals In | 3.6 | $12M | 641k | 18.54 | |
| Lyra Therapeutics (LYRA) | 3.3 | $11M | 2.8M | 3.91 | |
| Hillevax (HLVX) | 3.3 | $11M | 799k | 13.45 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 3.1 | $10M | 968k | 10.30 | |
| Zymeworks Del (ZYME) | 2.8 | $9.2M | 1.5M | 6.34 | |
| Rhythm Pharmaceuticals (RYTM) | 2.4 | $7.9M | 345k | 22.93 | |
| Tango Therapeutics (TNGX) | 2.2 | $7.1M | 630k | 11.26 | |
| Inozyme Pharma (INZY) | 2.0 | $6.6M | 1.6M | 4.20 | |
| Sutro Biopharma (STRO) | 1.8 | $5.8M | 1.7M | 3.47 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.7 | $5.7M | 348k | 16.30 | |
| Io Biotech (IOBT) | 1.6 | $5.1M | 3.6M | 1.41 | |
| Gossamer Bio (GOSS) | 1.6 | $5.1M | 6.1M | 0.83 | |
| Aclaris Therapeutics (ACRS) | 1.5 | $4.8M | 696k | 6.85 | |
| Immatics SHS (IMTX) | 1.4 | $4.6M | 396k | 11.58 | |
| Prime Medicine (PRME) | 1.4 | $4.5M | 470k | 9.54 | |
| Immunocore Hldgs Ads (IMCR) | 1.3 | $4.2M | 81k | 51.90 | |
| Nkarta (NKTX) | 1.2 | $4.0M | 2.9M | 1.39 | |
| Janux Therapeutics (JANX) | 1.1 | $3.6M | 360k | 10.08 | |
| Syros Pharmaceuticals Com New (SYRS) | 1.1 | $3.5M | 882k | 3.95 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.1 | $3.5M | 432k | 7.99 | |
| Pepgen (PEPG) | 1.0 | $3.3M | 651k | 5.08 | |
| Day One Biopharmaceuticals I (DAWN) | 0.7 | $2.4M | 196k | 12.27 | |
| Rain Therapeutics | 0.5 | $1.8M | 2.0M | 0.86 | |
| Igm Biosciences (IGMS) | 0.4 | $1.3M | 155k | 8.35 | |
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.1M | 1.0M | 1.04 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $1.0M | 202k | 5.03 | |
| Leap Therapeutics Com New (LPTX) | 0.3 | $831k | 602k | 1.38 | |
| Vtv Therapeutics Cl A | 0.2 | $782k | 1.6M | 0.48 | |
| Viracta Therapeutics (VIRX) | 0.2 | $717k | 690k | 1.04 | |
| Allakos (ALLK) | 0.1 | $391k | 172k | 2.27 | |
| Science 37 Holdings | 0.1 | $360k | 900k | 0.40 | |
| Allovir (ALVR) | 0.1 | $177k | 82k | 2.15 | |
| Kronos Bio (KRON) | 0.0 | $102k | 78k | 1.30 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $13k | 133k | 0.10 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $4.1k | 100k | 0.04 |
